Population and setting |
Country/region |
Sub-groups of patients with stroke |
Organisational structure (private/public) |
Care pathways |
Research question |
E.g. To determine/estimate the cost-effectiveness of intervention compared to comparator/control group |
Outcomes |
The outcome that is used for the cost-effectiveness measure |
Questionnaire used to estimate quality of life |
Treatment groups |
Intervention groups |
Comparator/control groups |
Perspective |
Health service |
Patient |
Societal |
Direct/indirect |
Study design / data source |
Alongside RCT |
Model-based economic evaluations using data from multiple sources |
Economic study design |
Cost benefit |
Cost effectiveness |
Cost utility |
Budget impact analysis |
Economic model |
E.g. Model assumptions, model name and reference in literature |
Reference year |
E.g. Year and inflation/deflation. Source for adjusting costs |
Time horizon |
Assumptions made for modelling longer-term costs and outcomes |
Discounting |
Nationally recommended – usually 3% or 5% |
Resource use collected |
E.g. Hospital readmissions, family physician contacts• Delivery of the intervention and justification for inclusion• If used, the method of estimating resource use based on clinical or demographic details of participants and the reference in literature |
Data collection methods |
Administrative data |
Patient self-report via survey |
Sub-group analysis |
Stroke type |
Hospital type (private/public) |
Sensitivity analysis |
Monte Carlo simulation (multivariable) |
One-way sensitivity |
Scenario analysis |
Funder |
Government |
Industry |
Private insurance |